Nektar Therapeutics

NKTRNASDAQ
$73.45
0.360.49%
At close: Aug 6, 5:00 PM EST
$73.45
N/A
After Hours: 4:00 PM EST
Earnings: Q2 2026 Earnings in 6 days from now on Thu Aug 13th, after the market close
Conference Call: Conference call scheduled in 6 days at 5:00 PM
Click to view the webcast

Nektar Therapeutics Ownership & Insider Activity

Nektar Therapeutics (NKTR) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 10.7% of shares outstanding. Institutional investors hold 39.8%. Over the past 90 days, insiders made 5 sales worth $2.0M.

Shares Outstanding

33.786M

Shares Float

30.618M

Insider Shares Owned

3.608M

Insider % Owned

10.7%

Institutional Shares Held

13.433M

Institutional % Held

39.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

5

$2.0M total

Net Activity

Net Selling

Net Value (90d)

-$2.0M

Nektar Therapeutics Insider Transactions (Last 6 Months)

DateInsiderTitleTypeSharesPriceValue
Jun 30, 2026Jonathan ZalevskyCHIEF R&D OFFICERSELL5.681K$70.00$398K
Jun 16, 2026HOWARD ROBINPRESIDENT & CEOSELL20.000K$60.75$1.2M